Dr. Umphrey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7600 Wolf River Blvd
Ste 200
Germantown, TN 38138Phone+1 901-747-1000Fax+1 901-747-1001
Education & Training
- University of Alabama Medical CenterResidency, Radiology-Diagnostic, 2005 - 2009
- University of Alabama Medical CenterFellowship, Neuropathology, 2004 - 2005
- University of Alabama Medical CenterResidency, Pathology-Anatomic and Clinical, 2002 - 2004
- University of Alabama HospitalInternship, Transitional Year, 2001 - 2002
- University of Alabama School of MedicineClass of 2001
Certifications & Licensure
- AR State Medical License 2017 - 2025
- MS State Medical License 2017 - 2025
- TN State Medical License 2017 - 2025
- AL State Medical License 2003 - 2024
- American Board of Pathology Anatomic Pathology
- American Board of Radiology Diagnostic Radiology
Clinical Trials
- DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy Start of enrollment: 2012 Aug 27
- Breast VCEUS to Evaluate Early Response to Neoadjuvant Chemotherapy Start of enrollment: 2015 Jun 01
Publications & Presentations
PubMed
- 67 citationsTest-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial.David C. Newitt, Zheng Zhang, Jessica Gibbs, Savannah C. Partridge, Thomas L. Chenevert
Journal of Magnetic Resonance Imaging. 2019-06-01 - 169 citationsDiffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter TrialSavannah C. Partridge, Zheng Zhang, David C. Newitt, Jessica Gibbs, Thomas L. Chenevert
Radiology. 2018-09-04 - 84 citationsArteriovenous Fistula Development in the First 6 Weeks after CreationMichelle L. Robbin, Tom Greene, Alfred K. Cheung, Michael Allon, Scott A. Berceli
Radiology. 2016-05-01
Press Mentions
- Predicting Breast Cancer Response to Neoadjuvant Treatment Using Multi-Feature MRI: Results from the I-SPY 2 TRIALNovember 27th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: